Preventive	JJ
and	CC
therapeutic	JJ
effects	NNS
of	IN
thymosin	NN
b4	NN
N-terminal	JJ
fragment	NN
Ac-SDKP	NN
in	IN
the	DT
bleomycin	NN
model	NN
of	IN
pulmonary	JJ
fibrosis	NN
.	.

In	IN
this	DT
study	NN
,	,
the	DT
bleomycin	NN
model	NN
of	IN
pulmonary	JJ
fibrosis	NN
was	VBD
utilized	VBN
to	TO
investigate	VB
putative	JJ
anti-fibrotic	JJ
activity	NN
of	IN
Ac-SDKP	NN
in	FW
vivo	FW
.	.

Male	JJ
CD-1	NN
mice	NNS
received	VBD
intra-tracheal	JJ
bleomycin	NN
(	(
BLEO	NN
,	,
1	CD
mg/kg	NN
)	)
instillation	NN
in	IN
the	DT
absence	NN
or	CC
presence	NN
of	IN
Ac-SDKP	NN
(	(
a	DT
dose	NN
of	IN
0.6	CD
mg/kg	NN
delivered	VBN
intra-peritoneally	RB
on	IN
the	DT
day	NN
of	IN
BLEO	NN
treatment	NN
,	,
d0	NN
,	,
followed	VBN
by	IN
bi-weekly	JJ
additional	JJ
doses	NNS
)	)
.	.

To	TO
evaluate	VB
therapeutic	JJ
effects	NNS
in	IN
a	DT
subset	NN
of	IN
mice	NNS
,	,
Ac-SDKP	NN
was	VBD
administered	VBN
one	CD
week	NN
after	IN
BLEO	NN
instillation	NN
(	(
d7	NN
)	)
.	.

Animals	NNS
were	VBD
sacrificed	VBN
at	IN
one	CD
,	,
two	CD
,	,
or	CC
three	CD
weeks	NNS
later	RB
.	.

Measurement	NN
of	IN
fluid	NN
and	CC
collagen	NN
content	NN
in	IN
the	DT
lung	NN
,	,
Broncho	NNP
Alveolar	JJ
Lavage	NN
Fluid	NN
(	(
BALF	NN
)	)
analysis	NN
,	,
lung	NN
histology	NN
,	,
immunohistochemistry	NN
(	(
IHC	NN
)	)
,	,
and	CC
molecular	JJ
analysis	NN
were	VBD
performed	VBN
.	.

Compared	VBN
to	TO
BLEO-treated	JJ
mice	NNS
,	,
animals	NNS
that	WDT
received	VBD
also	RB
Ac-SDKP	NN
(	(
at	IN
both	DT
d0	NN
and	CC
d7	NN
)	)
had	VBD
significantly	RB
decreased	VBN
mortality	NN
,	,
weight	NN
loss	NN
,	,
inflammation	NN
(	(
edema	NN
,	,
and	CC
leukocyte	NN
lung	NN
infiltration	NN
)	)
,	,
lung	NN
damage	NN
(	(
histological	JJ
evidence	NN
of	IN
lung	NN
injury	NN
)	)
,	,
and	CC
fibrosis	NN
(	(
collagen	NN
histological	JJ
staining	NN
and	CC
soluble	JJ
collagen	NN
content	NN
in	IN
the	DT
lung	NN
)	)
at	IN
up	RB
to	TO
21	CD
days	NNS
.	.

Moreover	RB
,	,
IHC	NNP
and	CC
quantitative	JJ
RT-PCR	NN
results	VBZ
demonstrated	VBD
a	DT
significant	JJ
decrease	NN
in	IN
BLEO-induced	JJ
IL-17	NN
and	CC
TGF-b	NN
expression	NN
in	IN
lung	NN
tissue	NN
.	.

Importantly	RB
,	,
a-SMA	NN
expression	NN
,	,
the	DT
hallmark	NN
of	IN
myofibroblast	NN
differentiation	NN
,	,
was	VBD
also	RB
decreased	VBN
.	.

This	DT
is	VBZ
the	DT
first	JJ
report	NN
showing	VBG
not	RB
only	RB
a	DT
preventive	JJ
protective	JJ
role	NN
of	IN
Ac-SDKP	NN
but	CC
also	RB
its	PRP$
significant	JJ
therapeutic	JJ
effects	NNS
in	IN
the	DT
bleomycin	NN
model	NN
of	IN
pulmonary	JJ
fibrosis	NN
,	,
thus	RB
supporting	VBG
further	JJ
preclinical	JJ
and	CC
clinical	JJ
studies	NNS
.	.

